Shannon Thyme Klinger insider trades

Open-market stock purchases and sales by Shannon Thyme Klinger, Chief Legal Officer at Moderna, Inc, from SEC Form 4 filings since Jun 7, 2021.

Recent trades

DateStockTradeValue
Sep 4, 2026MRNA Moderna, IncSold (not open market)$849K
Sep 4, 2026MRNA Moderna, IncBought (not open market)—
Sep 1, 2026MRNA Moderna, IncSold$486K
Sep 1, 2026MRNA Moderna, IncSold (not open market)$147K
Sep 1, 2026MRNA Moderna, IncBought (not open market)—
Sep 1, 2026MRNA Moderna, IncBought (not open market)—
Aug 28, 2026MRNA Moderna, IncSold (not open market)$22.8K
Aug 28, 2026MRNA Moderna, IncBought (not open market)—
Aug 27, 2026MRNA Moderna, IncBought (not open market)—
Aug 27, 2026MRNA Moderna, IncSold (not open market)$56.1K
Jun 5, 2026MRNA Moderna, IncSold (not open market)$294K
Jun 5, 2026MRNA Moderna, IncBought (not open market)—
Jun 4, 2026MRNA Moderna, IncSold$174K
Jun 4, 2026MRNA Moderna, IncBought (not open market)—
Jun 1, 2026MRNA Moderna, IncSold (not open market)$49.4K
Jun 1, 2026MRNA Moderna, IncBought (not open market)—
May 28, 2026MRNA Moderna, IncSold (not open market)$7.6K
May 28, 2026MRNA Moderna, IncBought (not open market)—
May 27, 2026MRNA Moderna, IncSold (not open market)$17.6K
May 27, 2026MRNA Moderna, IncBought (not open market)—
Mar 5, 2026MRNA Moderna, IncSold (not open market)$330K
Mar 5, 2026MRNA Moderna, IncBought (not open market)—
Mar 2, 2026MRNA Moderna, IncSold$726K
Mar 2, 2026MRNA Moderna, IncBought (not open market)—
Mar 1, 2026MRNA Moderna, IncBought (not open market)—

Companies traded

  • MRNA Moderna, Inc: 28 sales, last Sep 4, 2026
  • RFL Rafael Holdings, Inc: other filings, last Jan 5, 2022

Get free alerts when Shannon Thyme Klinger files a new trade →